313 related articles for article (PubMed ID: 19807696)
21. Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways.
Trouw LA; Haisma EM; Levarht EW; van der Woude D; Ioan-Facsinay A; Daha MR; Huizinga TW; Toes RE
Arthritis Rheum; 2009 Jul; 60(7):1923-31. PubMed ID: 19565507
[TBL] [Abstract][Full Text] [Related]
22. Structure and function of the long pentraxin PTX3 glycosidic moiety: fine-tuning of the interaction with C1q and complement activation.
Inforzato A; Peri G; Doni A; Garlanda C; Mantovani A; Bastone A; Carpentieri A; Amoresano A; Pucci P; Roos A; Daha MR; Vincenti S; Gallo G; Carminati P; De Santis R; Salvatori G
Biochemistry; 2006 Sep; 45(38):11540-51. PubMed ID: 16981714
[TBL] [Abstract][Full Text] [Related]
23. Studies on the interactions between C-reactive protein and complement proteins.
Bíró A; Rovó Z; Papp D; Cervenak L; Varga L; Füst G; Thielens NM; Arlaud GJ; Prohászka Z
Immunology; 2007 May; 121(1):40-50. PubMed ID: 17244159
[TBL] [Abstract][Full Text] [Related]
24. Mannan binding lectin and its interaction with immunoglobulins in health and in disease.
Arnold JN; Dwek RA; Rudd PM; Sim RB
Immunol Lett; 2006 Aug; 106(2):103-10. PubMed ID: 16814399
[TBL] [Abstract][Full Text] [Related]
25. Involvement of complement pathways in patients with bacterial septicemia.
Dumestre-Pérard C; Doerr E; Colomb MG; Loos M
Mol Immunol; 2007 Mar; 44(7):1631-8. PubMed ID: 17049606
[TBL] [Abstract][Full Text] [Related]
26. Complement-mediated inhibition of immune precipitation. I. Role of the classical and alternative pathways.
Schifferli JA; Woo P; Peters DK
Clin Exp Immunol; 1982 Mar; 47(3):555-62. PubMed ID: 6979442
[TBL] [Abstract][Full Text] [Related]
27. Activation of the classical pathway of complement by tobacco glycoprotein (TGP).
Koethe SM; Nelson KE; Becker CG
J Immunol; 1995 Jul; 155(2):826-35. PubMed ID: 7608560
[TBL] [Abstract][Full Text] [Related]
28. Low-molecular-weight heparin inhibition in classical complement activation pathway during pregnancy.
Oberkersch R; Attorresi AI; Calabrese GC
Thromb Res; 2010 May; 125(5):e240-5. PubMed ID: 20035973
[TBL] [Abstract][Full Text] [Related]
29. Complement C1q-target proteins recognition is inhibited by electric moment effectors.
Roumenina L; Bureeva S; Kantardjiev A; Karlinsky D; Andia-Pravdivy JE; Sim R; Kaplun A; Popov M; Kishore U; Atanasov B
J Mol Recognit; 2007; 20(5):405-15. PubMed ID: 17929239
[TBL] [Abstract][Full Text] [Related]
30. [The complement system--structure, activation, regulation and function].
Bjørge L
Tidsskr Nor Laegeforen; 1999 Jan; 119(2):226-33. PubMed ID: 10081355
[TBL] [Abstract][Full Text] [Related]
31. A small molecular weight factor in aqueous humor acts on C1q to prevent antibody-dependent complement activation.
Goslings WR; Prodeus AP; Streilein JW; Carroll MC; Jager MJ; Taylor AW
Invest Ophthalmol Vis Sci; 1998 May; 39(6):989-95. PubMed ID: 9579478
[TBL] [Abstract][Full Text] [Related]
32. cC1q-R (calreticulin) and gC1q-R/p33: ubiquitously expressed multi-ligand binding cellular proteins involved in inflammation and infection.
Ghebrehiwet B; Peerschke EI
Mol Immunol; 2004 Jun; 41(2-3):173-83. PubMed ID: 15159063
[TBL] [Abstract][Full Text] [Related]
33. C1, MBL-MASPs and C1-inhibitor: novel approaches for targeting complement-mediated inflammation.
Beinrohr L; Dobó J; Závodszky P; Gál P
Trends Mol Med; 2008 Dec; 14(12):511-21. PubMed ID: 18977695
[TBL] [Abstract][Full Text] [Related]
34. Factor H as a regulator of the classical pathway activation.
Kishore U; Sim RB
Immunobiology; 2012 Feb; 217(2):162-8. PubMed ID: 21852018
[TBL] [Abstract][Full Text] [Related]
35. Interaction between Schistosoma mansoni and the complement system: role of IgG Fc peptides in the activation of the classical pathway by schistosomula.
Ouaissi MA; Auriault C; Santoro F; Capron A
J Immunol; 1981 Oct; 127(4):1556-9. PubMed ID: 7024409
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic inhibition of the early phase of complement activation.
Roos A; Ramwadhdoebé TH; Nauta AJ; Hack CE; Daha MR
Immunobiology; 2002 Sep; 205(4-5):595-609. PubMed ID: 12396018
[TBL] [Abstract][Full Text] [Related]
37. Native, amyloid fibrils and beta-oligomers of the C-terminal domain of human prion protein display differential activation of complement and bind C1q, factor H and C4b-binding protein directly.
Sjöberg AP; Nyström S; Hammarström P; Blom AM
Mol Immunol; 2008 Jun; 45(11):3213-21. PubMed ID: 18406463
[TBL] [Abstract][Full Text] [Related]
38. Iron ions and haeme modulate the binding properties of complement subcomponent C1q and of immunoglobulins.
Dimitrov JD; Roumenina LT; Doltchinkova VR; Vassilev TL
Scand J Immunol; 2007 Mar; 65(3):230-9. PubMed ID: 17309777
[TBL] [Abstract][Full Text] [Related]
39. A dominant complement fixation pathway for pneumococcal polysaccharides initiated by SIGN-R1 interacting with C1q.
Kang YS; Do Y; Lee HK; Park SH; Cheong C; Lynch RM; Loeffler JM; Steinman RM; Park CG
Cell; 2006 Apr; 125(1):47-58. PubMed ID: 16615889
[TBL] [Abstract][Full Text] [Related]
40. Poly(ethylene glycol)s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process.
Hamad I; Hunter AC; Szebeni J; Moghimi SM
Mol Immunol; 2008 Dec; 46(2):225-32. PubMed ID: 18849076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
